SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon to spend 10% of its annual biopharma revenue on R&D in next fiscal year

02 Feb 2015 Evaluate

Biocon is planning to spend 10 per cent of its annual biopharma revenue on research and development (R&D) in the next fiscal year. The company, which is pursuing R&D in both novel biologics as well as biosimilars (generic versions of biologic drugs), in various stages of trials, had spent around Rs. 131 crore on R&D in the previous fiscal year which was 6 per cent of biopharma sales.

The pharma major has spent Rs 47 crore on R&D in the third quarter of this fiscal, an increase of 124 per cent over the corresponding period of the year-ago period. The firm earned revenues of Rs. 436 crore from its biopharma business during the quarter.

Biocon is India’s largest and Asia’s leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

361.40 2.90 (0.81%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×